Lorries queue on the A20 to enter the port of Dover in Kent.
Gareth Fuller | PA Images via Getty Image
LONDON – A highly contagious new form of coronavirus is causing it to block travel from Britain to Europe and elsewhere.
The UK last week warned of a new coronovirus variant that is believed to be up to 70% higher than the original strain of the disease. According to the World Health Organization, the new version has so far been identified in Denmark, the Netherlands and Australia.
News of the tensions forced the British government to plan to reunite families over Christmas, closing in London and other areas of southern England, where infection with Kovid’s mutation is heavily concentrated.
Over the weekend, several countries announced plans to close their borders to Britain. All flights from the UK are banned in Europe, France, Germany, Italy, Ireland and the Netherlands, while Austria and Sweden are reportedly preparing to do so.
France banned people coming from Britain and freight, whether by road, air, sea or rail, for 48 hours from Sunday night. The port of Dover was also closed to all vehicular traffic according to the UK Statement From the authorities. The move is expected to be Miles back-up.
On Monday, Britain’s Transport Secretary Grant Shapps said it was “a little surprised” that France had closed its border for hire.
Meanwhile, the German government suspended all flights from Britain from midnight on Sunday. Germany’s Health Minister Jens Spahn said Britain’s virus mutation had not yet been identified in the country.
The Belgian ban prevents flights and trains – including the popular Eurostar high-speed rail service – coming from the UK. Meanwhile, Italy has disrupted all flights in the country from 6 January. The Italian Ministry of Health has said the first case of the new virus was the variant reported in Rome. The Netherlands has banned flights from the UK until 1 January.
Ireland, which typically has significant passenger traffic with the UK at this time of year, announced that flights coming from England, Wales and Scotland would be banned for at least 48 hours from midnight.
The UK government said it would hold a crisis meeting on Monday to discuss the status of international travel. The European Council is expected to hold talks on a coordinated EU response as the new Kovid at 10 am London time.
The situation may further complicate Brexit negotiations. The UK and the EU remain at a deadlock over Brexit trade relations with post-Brexit disputes as of the 31 December deadline, such as disputes over negotiations on fisheries. Actual Sank sharply against the dollar1.2% drop to around $ 1.34.
Other countries including Canada and Israel have also implemented new measures preventing flights from the UK.
Professor Chris Whitty, Chief Medical Officer of England, Said on saturday That the UK had identified a new Kovid version that “could spread more quickly” than earlier strains.
It is unclear whether the new strain spreads more easily, makes people sick or changes the way their immune system reacts to the virus if they were previously infected or vaccinated. So far, Whitty said, studies show that the new strain is significantly more permeable, but there is no evidence to suggest that it causes a high mortality rate.
Whitty said there was a “working perception” that vaccines should still work against mutant strain.
British Health Secretary Matt Hancock said on Sunday that the new version was “out of control” and suggested that it might be months before the strictest coronovirus restrictions would be allowed to end.
“The new version is out of control and we need to get it under control,” Hancock told the BBC’s Andrew Marr program on Sunday.
“Inevitably, the vaccine is introduced to keep us safe,” Hancock said in a separate interview with Sky News.
“I think, given how fast this new version spreads, it will be very difficult to keep it under control until we have the vaccine rolled out.”
The UK was the first country to introduce a pioneering Kovid vaccine – namely, developed by Pfizer and BioNotech. Vaccines are currently being administered to the most vulnerable in the UK, and it is unclear when they will become more widely available.